Loading patent…
AssigneeCargill, Incorporated
InventorsMichael LYNCH, Michael LOUIE, Shelley COPLEY, Eileen SPINDLER, Brittany PRATHER, Matthew LIPSCOMB, Tanya LIPSCOMB, Hans LIAO, Dave HOGSETT, Ron EVANS
Estimating the term…
This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism.
A genetically modified organism comprising a heterologous nucleic acid sequence encoding a 3-ketoacyl-CoA synthase, a ketoacyl-CoA reductase, a hydroxyacyl-CoA dehydratase, or an enoyl-CoA reductase, and a wax ester synthase;
-9. (canceled)
-19. (canceled)
-24. (canceled)
-28. (canceled)
(canceled)
(canceled)
-40. (canceled)
(canceled)
A genetically modified organism comprising a heterologous nucleic acid sequence encoding a 3-ketoacyl-CoA synthase, a ketoacyl-CoA reductase, a hydroxyacyl-CoA dehydratase, or an enoyl-CoA reductase;
Dependencies are inferred from the claim text.